'Steve 2.0': Proton Therapy, Transplant Experts Helps Patient Start Over
Second chances are often golden opportunities to improve one's self.
For Steve Roberto, discovering in his 50s that he had been living with hepatitis C for decades was the beginning of a series of health challenges, but ultimately, he would get a unique chance to hit the reset button on life.
Cured of his hepatitis C after three years, he would still eventually need a liver transplant. Roberto was referred to UC Health, the only liver transplant program in the region.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.